How would you manage IVF using ovarian stimulation in a woman with a prior estrogen related thrombotic event?
In a woman with a prior estrogen related thrombotic event, how would you manage IVF?
Join Mednetto vote and see how they answered.
This is a very important question. In general, guidelines do not necessarily cover this very specific area. A couple of important points to think about are that (1) women with a history of VTE provoked in the setting of estrogen therapy – for example, contraceptive use – are advised to undergo pharmacologic prophylaxis during pregnancy due to increased estrogen levels during pregnancy and (2) ovarian stimulation protocols lead to significantly increased levels of endogenous estrogen. While guidelines strongly recommend pharmacologic prophylaxis specifically for those women who develop ovarian hyperstimulation syndrome (OHSS) during stimulation protocols as OHSS is a strong risk factor for VTE, it physiologically stands to reason that the significant increase in estrogen levels during stimulation protocols poses a relatively high risk of VTE to those women with prior estrogen-provoked VTE events. Therefore, I would advise OB-GYNs and hematologists to at least have an informed discussion with patients with estrogen-provoked VTE history starting a stimulation protocol that pharmacologic prophylaxis is something to consider. What type of prophylaxis? Likely enoxaparin, since the DOACs are not yet approved for use during pregnancy (mostly based on the absence of evidence of safety, not the presence of evidence of harm).